IBEX stock hits 52-week high at $22.58 amid robust growth

Published 30/01/2025, 15:44
IBEX stock hits 52-week high at $22.58 amid robust growth

IBEX Holdings Ltd , a global provider of contact center services and other business process outsourcing solutions, has reached a new 52-week high, with its stock price climbing to $22.58. The company, currently trading at an attractive P/E ratio of 11.4x and generating over $513 million in annual revenue, appears undervalued according to InvestingPro analysis. This milestone reflects a significant uptrend in the company’s market performance, underpinned by strategic expansions and a strong customer base. Over the past year, IBEX has witnessed a remarkable 24.81% increase in its stock value, with management actively buying back shares, signaling investor confidence and a positive outlook. The company maintains a "GREAT" financial health score and operates with moderate debt levels, according to InvestingPro, which offers 13 additional key insights about IBEX’s potential. The achievement of this 52-week high serves as a testament to IBEX’s operational success and its ability to adapt and thrive in the dynamic outsourcing industry.

In other recent news, IBEX Ltd (NASDAQ:IBEX) has successfully completed a $70 million share repurchase, fully settling a convertible promissory note. The transaction, which involved the repurchase of 3,562,341 common shares from The Resource Group International Limited, marks a significant shift in the company’s capital structure. This development coincides with a robust financial performance for IBEX Ltd, which reported a record Q1 revenue of $129.7 million, a 4.1% increase from the previous year. The adjusted EBITDA rose to $15.6 million, while the adjusted EPS saw a 30% increase to $0.52. Consequently, the company has raised its full-year revenue guidance to between $515 million and $525 million.

In addition to these financial milestones, IBEX Ltd has seen significant changes in its governance structure. The company’s shareholders have approved several key proposals, including setting the size of the board of directors, electing directors, and appointing the company’s auditor for the upcoming fiscal year. These developments follow the company’s share repurchase, which has ended its status as a "controlled company" under Nasdaq rules.

Analysts from InvestingPro have noted the company’s aggressive share buyback programs and strong commitment to shareholder value. The firm’s analysis shows that IBEX Ltd maintains a "GREAT" financial health score, supported by robust liquidity and efficient operations. As the company continues to navigate these recent developments, it remains to be seen how these strategic decisions will shape its future trajectory.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.